scispace - formally typeset
Open AccessJournal ArticleDOI

Prophylaxis of post-ERCP pancreatitis: European society of gastrointestinal endoscopy (ESGE) guideline - Updated June 2014

Reads0
Chats0
TLDR
Routine rectal administration of 100 mg of diclofenac or indomethacin immediately before or after ERCP in all patients without contraindication is recommended and needle-knife fistulotomy should be the preferred precut technique in patients with a bile duct dilated down to the papilla.
Abstract
This Guideline is an official statement of the European Society of Gastrointestinal Endoscopy (ESGE). It addresses the prophylaxis of post-endoscopic retrograde cholangiopancreatography (post-ERCP) pancreatitis. Main recommendations 1 ESGE recommends routine rectal administration of 100 mg of diclofenac or indomethacin immediately before or after ERCP in all patients without contraindication. In addition to this, in the case of high risk for post-ERCP pancreatitis (PEP), the placement of a 5-Fr prophylactic pancreatic stent should be strongly considered. Sublingually administered glyceryl trinitrate or 250 µg somatostatin given in bolus injection might be considered as an option in high risk cases if nonsteroidal anti-inflammatory drugs (NSAIDs) are contraindicated and if prophylactic pancreatic stenting is not possible or successful. 2 ESGE recommends keeping the number of cannulation attempts as low as possible. 3 ESGE suggests restricting the use of a pancreatic guidewire as a backup technique for biliary cannulation to cases with repeated inadvertent cannulation of the pancreatic duct; if this method is used, deep biliary cannulation should be attempted using a guidewire rather than the contrast-assisted method and a prophylactic pancreatic stent should be placed. 4 ESGE suggests that needle-knife fistulotomy should be the preferred precut technique in patients with a bile duct dilated down to the papilla. Conventional precut and transpancreatic sphincterotomy present similar success and complication rates; if conventional precut is selected and pancreatic cannulation is easily obtained, ESGE suggests attempting to place a small-diameter (3-Fr or 5-Fr) pancreatic stent to guide the cut and leaving the pancreatic stent in place at the end of ERCP for a minimum of 12 – 24 hours. 4 ESGE does not recommend endoscopic papillary balloon dilation as an alternative to sphincterotomy in routine ERCP, but it may be advantageous in selected patients; if this technique is used, the duration of dilation should be longer than 1 minute.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Adverse events associated with ERCP

TL;DR: Vinay Chandrasekhara, MD, Mouen A. Khashab,MD, V. Raman Muthusamy, PhD, FASGE, Ruben D. Acosta, MD; Deepak Agrawal, MD , MPH, David H. Lightdale, MD*, MPH, FasGE, NASPGHAN Representative.
References
More filters
Journal ArticleDOI

Randomized controlled trial.

Journal ArticleDOI

Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus

TL;DR: This international, web-based consensus provides clear definitions to classify acute pancreatitis using easily identified clinical and radiologic criteria and should encourage widespread adoption.
Journal ArticleDOI

Endoscopic sphincterotomy complications and their management: an attempt at consensus

TL;DR: This document is an attempt to provide guidelines for prevention and management of complications, based on a workshop of selected experts, and a comprehensive review of the literature, that emphasize the importance of specialist training, disinfection, drainage, and collaboration with surgical colleagues.
Journal ArticleDOI

Complications of Endoscopic Biliary Sphincterotomy

TL;DR: The rate of complications after endoscopic biliary sphincterotomy can vary widely in different circumstances and is primarily related to the indication for the procedure and to endoscopic technique, rather than to the age or general medical condition of the patients.
Journal ArticleDOI

Risk factors for post-ERCP pancreatitis: A prospective, multicenter study

TL;DR: Combinations of patient characteristics including female gender, normal serum bilirubin, recurrent abdominal pain, and previous post-ERCP pancreatitis placed patients at increasingly higher risk of pancreatitis, regardless of whether ERCP was diagnostic, manometric, or therapeutic.
Related Papers (5)